STAAR Surgical Company (FRA:SR3)
Germany flag Germany · Delayed Price · Currency is EUR
22.25
-0.44 (-1.94%)
Last updated: Dec 2, 2025, 8:01 AM CET

STAAR Surgical Company Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company
CountryUnited States
Founded1982
IndustryOphthalmic Goods
Employees1,157
CEOStephen Farrell

Contact Details

Address:
25510 Commercentre Drive
Lake Forest, Delaware 92630
United States
Phone626 303 7902
Websitestaar.com

Stock Details

Ticker SymbolSR3
ExchangeFrankfurt Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3851

Key Executives

NamePosition
Stephen FarrellChief Executive Officer
Deborah AndrewsChief Financial Officer
Warren FoustChief Operating Officer